| Boston’s Life Science Disruptors: The Photos | Ben Fidler | 10/27/16 | Boston |
| Last Chance to Save on Boston’s Life Science Disruptors on 10/20 | Ashley Gentile | 10/17/16 | Boston |
| Procrastinator’s Special Ends Thursday for Boston’s Life Science Disruptors | Ashley Gentile | 10/12/16 | Boston |
| Intellia Execs Talk CRISPR’s Path Forward at Xconomy’s Oct. 20 Event | Ben Fidler | 10/06/16 | Boston |
| Gene Editing, Precision Medicine & More at Disruptors on Oct. 20 | Ashley Gentile | 09/29/16 | Boston |
| Talk Bio Diversity With Sato, McGuire at Disruptors on Oct. 20 | Ben Fidler | 09/22/16 | Boston |
| CRISPR and More at Boston’s Life Science Disruptors Oct. 20 | Ben Fidler | 08/17/16 | Boston |
| Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases | Ben Fidler | 06/22/16 | Boston |
| With $30M, Spero Broadens Fight Against Drug-Resistant Bugs | Ben Fidler | 06/08/15 | Boston |
| Well-Traveled Rhodes Leaves Epizyme For Atlas Venture Partnership | Alex Lash | 09/29/14 | Boston |
| Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs | Ben Fidler | 04/09/14 | Boston |
| Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim | Ben Fidler | 02/18/14 | Boston |
| East Coast Life Sciences Roundup: Aileron, Enzymatics, Acton, & More | Ben Fidler | 09/06/13 | Boston |
| Atlas Leans on Amgen, Novartis to Build New Startups | Ben Fidler | 05/16/13 | Boston |
| Annovation Adds $8M to Develop Safer, More Precise Anesthesia | Erin Kutz | 09/10/12 | Boston |
| RaNA Raises $20.7M From Atlas, SR One, Monsanto, for RNA-Based Tech | Arlene Weintraub | 01/18/12 | Boston |
| Arteaus, With $18M From Atlas and OrbiMed, Forges Ahead on Migraine-Prevention Drug | Arlene Weintraub | 10/19/11 | Boston |
| Atlas and Monsanto the Latest VC and Big Co. Getting Close | Ryan McBride | 04/14/11 | Boston |
| John Mendlein, Biotech Exec With Surfer Look, Follows Winding Path as “Parallel Entrepreneur” | Luke Timmerman | 01/03/11 | San Diego |
| A One-Size-Fits-All License Agreement: The Holy Grail of Tech Transfer? | Sylvia Pagán Westphal | 09/21/10 | National |
| XSITE’s Biotech Gurus to Cover the State of New England Biotech, the Return of Platforms | Luke Timmerman | 06/07/10 | Boston |
| Bio Bigwigs from Boston and Beyond Gather in Cambridge to Discuss Future of Drug Development, Venture Capital, and Deals with Pharma | Ryan McBride | 04/08/09 | Boston |
| Atlas Venture Closes New Fund with $283M, Does the Staffing Shuffle | Rebecca Zacks | 01/29/09 | Boston |
